153 related articles for article (PubMed ID: 23519293)
1. Cost-utility estimations of palliative care in patients with pancreatic adenocarcinoma: a retrospective analysis.
Ljungman D; Hyltander A; Lundholm K
World J Surg; 2013 Aug; 37(8):1883-91. PubMed ID: 23519293
[TBL] [Abstract][Full Text] [Related]
2. Cost-utility estimation of surgical treatment of pancreatic carcinoma aimed at cure.
Ljungman D; Lundholm K; Hyltander A
World J Surg; 2011 Mar; 35(3):662-70. PubMed ID: 21132294
[TBL] [Abstract][Full Text] [Related]
3. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
[TBL] [Abstract][Full Text] [Related]
4. Staging laparoscopy for proximal pancreatic cancer in a magnetic resonance imaging-driven practice: what's it worth?
Tapper E; Kalb B; Martin DR; Kooby D; Adsay NV; Sarmiento JM
HPB (Oxford); 2011 Oct; 13(10):732-7. PubMed ID: 21929674
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
6. Is resection appropriate for adenocarcinoma of the pancreas? A cost-benefit analysis.
Lea MS; Stahlgren LH
Am J Surg; 1987 Dec; 154(6):651-4. PubMed ID: 2447808
[TBL] [Abstract][Full Text] [Related]
7. Healthcare costs, treatment patterns, and resource utilization among pancreatic cancer patients in a managed care population.
DaCosta Byfield S; Nash Smyth E; Mytelka D; Bowman L; Teitelbaum A
J Med Econ; 2013 Dec; 16(12):1379-86. PubMed ID: 24074258
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial.
Halling CMB; Wolf RT; Sjøgren P; Von Der Maase H; Timm H; Johansen C; Kjellberg J
BMC Palliat Care; 2020 Sep; 19(1):142. PubMed ID: 32933489
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma.
Abbott DE; Tzeng CW; Merkow RP; Cantor SB; Chang GJ; Katz MH; Bentrem DJ; Bilimoria KY; Crane CH; Varadhachary GR; Abbruzzese JL; Wolff RA; Lee JE; Evans DB; Fleming JB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S500-8. PubMed ID: 23397153
[TBL] [Abstract][Full Text] [Related]
10. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
11. Defining Value for Pancreatic Surgery in Early-Stage Pancreatic Cancer.
Bateni SB; Gingrich AA; Hoch JS; Canter RJ; Bold RJ
JAMA Surg; 2019 Oct; 154(10):e193019. PubMed ID: 31433465
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement.
Abbott DE; Merkow RP; Cantor SB; Fleming JB; Varadhachary GR; Crane C; Bentrem DJ; Bilimoria KY
Ann Surg Oncol; 2012 Nov; 19(12):3659-67. PubMed ID: 22965567
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefit and cost effectiveness of total knee arthroplasty in the older patient.
Krummenauer F; Wolf C; Günther KP; Kirschner S
Eur J Med Res; 2009; 14(2):76-84. PubMed ID: 19258217
[TBL] [Abstract][Full Text] [Related]
14. Modeled cost-effectiveness of transforaminal lumbar interbody fusion compared with posterolateral fusion for spondylolisthesis using N(2)QOD data.
Carreon LY; Glassman SD; Ghogawala Z; Mummaneni PV; McGirt MJ; Asher AL
J Neurosurg Spine; 2016 Jun; 24(6):916-21. PubMed ID: 26895529
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
16. Economic value of treating lumbar disc herniation in Brazil.
Falavigna A; Scheverin N; Righesso O; Teles AR; Gullo MC; Cheng JS; Riew KD
J Neurosurg Spine; 2016 Apr; 24(4):608-14. PubMed ID: 26654336
[TBL] [Abstract][Full Text] [Related]
17. How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study.
Wang JP; Wu CY; Hwang IH; Kao CH; Hung YP; Hwang SJ; Li CP
BMC Palliat Care; 2016 Jan; 15():1. PubMed ID: 26746232
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach.
Tingstedt B; Andersson E; Flink A; Bolin K; Lindgren B; Andersson R
World J Surg; 2011 Oct; 35(10):2298-305. PubMed ID: 21850604
[TBL] [Abstract][Full Text] [Related]
19. Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer.
Raikar GV; Melin MM; Ress A; Lettieri SZ; Poterucha JJ; Nagorney DM; Donohue JH
Ann Surg Oncol; 1996 Sep; 3(5):470-5. PubMed ID: 8876889
[TBL] [Abstract][Full Text] [Related]
20. An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer.
Mortenson MM; Ho HS; Bold RJ
Am J Surg; 2005 Sep; 190(3):406-11. PubMed ID: 16105527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
